We are live on ! Find out more
OA

Oxbow Advisors Portfolio holdings

AUM $1.18B
1-Year Est. Return 28.15%
This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+28.15%
3 Year Est. Return
+72.79%
5 Year Est. Return
+88.47%
10 Year Est. Return
+169.66%
AUM
$1.01B
AUM Growth
+$156M
Cap. Flow
+$109M
Cap. Flow %
10.79%
Top 10 Hldgs %
46.73%
Holding
245
New
15
Increased
88
Reduced
62
Closed
28

Sector Composition

Rank Sector Weight
1 Energy 13.84%
2 Technology 9.19%
3 Healthcare 6.17%
4 Materials 5.94%
5 Financials 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCO icon
26
Moody's
MCO
$81.7B
$9.57M 0.95%
20,166
-185
-0.9% -$85.7K
SLV icon
27
iShares Silver Trust
SLV
$28.1B
$9.3M 0.92%
327,295
+24,747
+8% +$665K
LOW icon
28
Lowe's Companies
LOW
$116B
$8.93M 0.89%
32,978
-290
-0.9% -$70.2K
DOC icon
29
Healthpeak Properties
DOC
$15.4B
$8.58M 0.85%
+374,956
New +$8.08M
EWU icon
30
iShares MSCI United Kingdom ETF
EWU
$4.04B
$8.45M 0.84%
225,891
+966
+0.4% +$35.1K
UL icon
31
Unilever
UL
$131B
$8.21M 0.81%
112,317
+630
+0.6% +$43.5K
NEM icon
32
Newmont
NEM
$98.2B
$7.88M 0.78%
147,380
-1,632
-1% -$81.1K
ET icon
33
Energy Transfer Partners
ET
$70.1B
$7.54M 0.75%
469,920
-16,090
-3% -$259K
TPYP icon
34
Tortoise North American Pipeline ETF
TPYP
$900M
$7.29M 0.72%
232,425
-14,953
-6% -$454K
MCD icon
35
McDonald's
MCD
$188B
$7.27M 0.72%
23,869
+353
+2% +$97.3K
JNJ icon
36
Johnson & Johnson
JNJ
$635B
$6.7M 0.66%
41,323
+1,474
+4% +$235K
GLD icon
37
SPDR Gold Trust
GLD
$131B
$6.64M 0.66%
27,334
+157
+0.6% +$36K
JPST icon
38
JPMorgan Ultra-Short Income ETF
JPST
$40B
$6.51M 0.65%
128,313
+7,295
+6% +$369K
KMB icon
39
Kimberly-Clark
KMB
$36.4B
$6.09M 0.6%
42,793
-26
-0.1% -$3.69K
GILD icon
40
Gilead Sciences
GILD
$161B
$5.99M 0.59%
71,491
-53
-0.1% -$4.04K
SNY icon
41
Sanofi
SNY
$104B
$5.76M 0.57%
99,959
+233
+0.2% +$12.6K
GSK icon
42
GSK
GSK
$103B
$5.75M 0.57%
140,735
+4,430
+3% +$181K
KO icon
43
Coca-Cola
KO
$354B
$5.75M 0.57%
80,003
+981
+1% +$67.2K
NTR icon
44
Nutrien
NTR
$32.7B
$5.74M 0.57%
119,450
+48,645
+69% +$2.34M
CI icon
45
Cigna
CI
$76.6B
$5.66M 0.56%
16,333
-76
-0.5% -$26.2K
ETR icon
46
Entergy
ETR
$54.1B
$5.65M 0.56%
85,830
-128
-0.1% -$7.54K
RSP icon
47
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$5.63M 0.56%
31,398
-385
-1% -$65.8K
MRK icon
48
Merck
MRK
$324B
$5.6M 0.56%
49,278
+25,836
+110% +$3.07M
UGI icon
49
UGI
UGI
$8B
$5.49M 0.54%
219,505
+3,181
+1% +$76.6K
ELV icon
50
Elevance Health
ELV
$81.9B
$5.42M 0.54%
10,426
+54
+0.5% +$28.8K

Similar funds

Oxbow Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Oxbow Advisors held 245 positions worth $1.01B, up 18% from $852M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oxbow Advisors deployed $109M of net new capital in Q3 2024, opening 15 new positions and adding to 88 existing holdings. Its largest new stake was Healthpeak Properties: 374,956 shares worth $8.58M.

By sector, the portfolio is most concentrated in Energy at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was VanEck Junior Gold Miners ETF, an estimated $1.73M trimmed.

  • Oxbow Advisors's largest Q3 2024 buy was Healthpeak Properties: 374,956 shares worth $8.58M.
  • Oxbow Advisors added most to iShares Treasury Floating Rate Bond ETF in Q3 2024, an estimated $50.5M increase.
  • Oxbow Advisors's biggest Q3 2024 reduction was VanEck Junior Gold Miners ETF, cutting an estimated $1.73M.
  • Oxbow Advisors fully exited Accenture in Q3 2024, selling an estimated $7.44M.
  • Oxbow Advisors's ten largest holdings make up 47% of its $1.01B portfolio in Q3 2024.
  • Oxbow Advisors opened 15 new positions and closed 28 in Q3 2024.
  • Oxbow Advisors's portfolio value rose 18% quarter-over-quarter to $1.01B.

Based on Oxbow Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.